Tag: Japan

ONPATTRO for the Treatment of Hereditary ATTR Amyloidosis with Polyneuropathy Approved in Japan

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved ONPATTRO®(patisiran) for the treatment of h...

AstraZeneca’s Breztri Aerosphere Approved in Japan

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy to relieve symptoms of chronic...

Roche’s Personalised Medicine Rozlytrek Approved in Japan

roche
Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of adult and paediatric patients with neurotrophic tyrosine receptor ...

Takeda’s Entyvio® Received Approval in Japan

drugsapproved
Takeda Pharmaceutical Company Limited announced that it has obtained approval from the Ministry of Health, Labour and Welfare (MHLW) for an additional indication for Entyvio® (generic name: vedolizuma...

Forxiga Got Another Approval

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Forxiga (dapagliflozin) as an oral adjunct treatment to insulin for adults with type-1 diabetes (T1D). Elisabeth Björk, Senio...

GARDP, Eisai and Takeda join Forces to search new Antibiotics

Under a new agreement the Japanese pharma companies will access and screen molecules from Eisai and Takeda’s chemical libraries. Both libraries will be tested by the Institut Pasteur Korea, in order t...

Sun Pharma to acquire Japanese drug manufacturer

sun pharma
Sun Pharma announced it has entered into a agreement to acquire Pola Pharma, a company engaged in research and development, manufacture, sale and distribution of branded and generic products.

Alvotech and Fuji Pharma signed an exclusive partnership agreement

clinical-trials
Alvotech (Iceland) and Fuji Pharma (Japan) announced that the two companies are entering into an exclusive partnership.

The leading marketplace for scientific services opens office in Tokyo

chemistry
Scientist.com, the world's leading marketplace for outsourced scientific services, announced it will expand to Japan, opening an office in Tokyo (Japan).

Japanese pharma industry energized by the next wave of growth

japan
Japan’s pharmaceutical industry is the third largest worldwide after the US and China with a share of approximately ten percent of the world market and a value expected to reach $109 billion by 2026.

AGC Biologics will set up a new facility in Japan

test tube
AGC Biologics announced that it will establish a new state of the art process development and manufacturing facility at its CDMO facility in Chiba (Japan).

Canon Medical establishes a joint company with ACT Genomics

scientist
Canon Medical System Corporation completed the acquisition of the majority shares of ACTmed, a joint venture company established with ACT Genomics, a Taiwanese molecular diagnostic company.

EU and Japan strenghten collaboration on inspections of drug manufacturers

drugs
The European Union (EU) and Japan have agreed to broaden the range of medicines for which they will recognise each other’s inspections of manufacturing sites.

LG Chem start to market etanercept biosimilar in Japan

biosimilars
LG Chem Ltd., South Korea's leading chemical company, begun selling its biosimilar etanercept for the treatment of rheumatoid arthritis in Japan.

Eurofins Scientific seals an outsourcing deal with Astellas

lab
Eurofins Scientific, a global leader in biopharmaceutical products testing services, announces that it has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories.

First trials of stem-cell based heart treatment were approved in Japan

stem-cell
This would be the second instance of using iPS-derived cells for disease treatment in Japan, after groundbreaking trials involving retinal cells launched in 2014.